Scarring is reduced when heart attack patients receive stem cells

09/11/2013 | TCTMD.com

Treatment with autologous cardiac progenitor cells was linked with reductions in scar tissue and improvements in viable myocardium after a heart attack, according to a study in the Journal of the American College of Cardiology. Improved systolic function and greater scar tissue improvements were seen in the treatment group compared with controls, according to the 25-patient study, which was conducted at two centers.

View Full Article in:

TCTMD.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY